Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,551 total articles
60 Degrees Pharmaceuticals announced that interim analysis results from its clinical study of tafenoquine in severe babesiosis will be released on October 6, 2026. The company will host an investor webinar featuring leading babesiosis experts discussing the unmet medical needs and potential role of tafenoquine. Tafenoquine is approved for malaria p…
Global-e Online Ltd., a leading global e-commerce platform, announced that Tomer Gold, previously Executive Vice President of SMB & Channel division, will become Chief Revenue Officer effective October 1, 2026. The outgoing CRO, Ran Fridman, is departing after over five years of service. The company expects Gold's leadership to support the next pha…
Alignment Healthcare announces major expansion of its Medicare Advantage portfolio for 2027, adding coverage in 10 new counties across five states and partnering with prominent providers like Hoag and Astrana Health. The company introduces new culturally connected plans, enhanced pharmacy benefits, and supplemental services, supported by its propri…
Pasqal, a Nasdaq-listed leader in neutral-atom quantum computing, announced the appointment of Florence Lao as Chief Legal Officer. Lao brings nearly 20 years of international legal experience to oversee corporate governance, compliance, and strategic growth as Pasqal expands globally.
Aktis Oncology has initiated the Phase 1b BActinium-2 clinical trial to evaluate AKY-2519, a miniprotein radioconjugate targeting B7-H3 expressing tumors such as non-small cell lung cancer (NSCLC). This trial complements the ongoing Phase 1b BActinium-1 trial in metastatic castration-resistant prostate cancer, with preliminary data expected in 2027…
Lands' End, Inc. announced its participation in the 2026 Global Consumer & Retail Conference hosted by Telsey Advisory Group and Santander Corporate & Investment Banking. The company's CEO Charlie Cole and CFO Bernie McCracken will present in a fireside chat on October 8, 2026, with the session webcast live. Lands' End is a leading digital retailer…
Genius Group Limited's CEO and Founder, Roger Hamilton, purchased an additional 1,000,000 shares on the open market at $0.15 per share, reflecting his continued confidence in the company's future following strong operational and legal progress in 2026. Hamilton has acquired a total of 6.5 million shares since January 2024. Genius Group is a global …
Vertex, Inc., a global leader in indirect tax and compliance solutions, has appointed Debanjan Saha, CEO of DataRobot, to its Board of Directors. Saha brings extensive experience in AI, data, and cloud technologies, positioning Vertex to enhance its AI-first strategy and drive innovation in tax automation and compliance for enterprise clients world…
SLR Investment Corp., a NASDAQ-listed business development company specializing in middle market lending, announced the release date for its Q3 2026 financial results and the scheduling of its earnings conference call and webcast. The company focuses on investing in senior secured loans and asset-based loans to U.S. middle market companies.
Veea Inc. announced a significant agreement with TROLLEE Holdings Limited for the phased deployment of VeeaONE edge computing solutions in 1,000 unattended retail stores. The deployment will facilitate AI-powered applications such as loss prevention, store safety, predictive maintenance, and smart retail monitoring by integrating VeeaHubs and NVIDI…
Daxor Corporation announced the showcase of its FDA 510(k)-cleared next-generation Blood Volume Analyzer at the Heart Failure Society of America Annual Meeting. The new platform delivers test results three times faster using 50% less blood while maintaining high accuracy, aiming to improve clinical workflow and outcomes in heart failure management.…
NANO Nuclear Energy Inc. announced a definitive agreement to acquire NRC-licensed U.S. nuclear fuel processing assets, including a license for a depleted uranium hexafluoride deconversion facility in New Mexico. This acquisition advances the company's vertical integration strategy by providing a regulatory and technical foundation to pursue domesti…
Powerus Corporation completed its merger with Aureus Greenway Holdings (AGH) effective October 1, 2026, retaining the Nasdaq ticker symbol PUSA. The merger consolidates Powerus as a public company focused on autonomous systems for defense and agriculture markets. Several strategic contracts, partnerships, and manufacturing expansions underpin the c…
Namib Minerals announced strong financial results for the first half of 2026, with revenue up 40% and adjusted EBITDA up 76%, driven by higher gold prices and cost controls. The company substantially completed expansion of the How Mine milling plant, increasing processing capacity by 36%, with commissioning expected mid-October. The accelerated res…
SpyGlass Pharma has acquired Advanced Vision Science, Inc. (AVS) for ~$13 million to secure scalable manufacturing of intraocular lenses (IOLs) for its lead product, the BIM-IOL System, which is in two Phase 3 trials. The acquisition accelerates the company’s ability to develop premium lens options integrated with its sustained drug delivery techno…
Apollo has expanded its daily pricing initiative across its $850 billion private credit business, extending timely and standardized valuation data to investors in various credit vehicles. This step forms part of Apollo's broader efforts to increase transparency, support secondary market liquidity, and align private credit with public market practic…
Gentex Corporation, a supplier of digital vision, connected car, dimmable glass, fire protection technologies, and consumer electronics, will release its third quarter 2026 financial results on October 23, 2026, before market open, followed by a conference call for investors at 9:30am ET.
Next Technology Holding Inc. has approved a $35 million research and development budget for September 2026 to March 2027 aimed at enhancing its AI-driven SaaS platforms, AI computing power capabilities, and robotics technologies. The initiative seeks to accelerate business expansion and strengthen the company's competitive edge within key emerging …
PMGC Holdings Inc. completed a $100 million SPAC IPO for NorthStrive Acquisition Corp I (Nasdaq: NSAI), marking the launch of its SPAC sponsorship platform aimed at enabling larger-scale mergers and acquisitions in aerospace, defense, industrial technology, and critical supply chains. This initiative complements PMGC's existing acquisition strategy…
Stryker Corporation, a global leader in medical technologies, will release its third quarter 2026 financial results on October 29, 2026, followed by a webcast to discuss the performance. A press release with summary financial information will be issued shortly before the webcast, providing investors and analysts access to the company's latest finan…
Linkhome Holdings Inc. has launched GPU Marketplace 2.0, a public platform enabling customers to rent GPU computing capacity from individuals and data centers. The marketplace aims to improve access to on-demand AI computing resources and optimize the use of idle GPUs, supporting NVIDIA GPUs like GeForce RTX 5090, H100, and B200. While the platform…
Aptera Motors Corp. announced a reduced capital requirement to start production of its solar electric vehicles, lowering estimates from $40-$45 million to approximately $25 million. The company attributes these savings to a strategic partnership with Launch Design which improves manufacturing efficiencies and supplier access. The first 40 productio…
Clover Health announced its 2027 Medicare Advantage plans featuring $0 to low premium PPO options, broad provider networks with no referrals required, and inclusion of preventive care benefits. Powered by its Clover Assistant platform, the plans focus on improving clinical decision-making and member outcomes. The company's approach targets affordab…
Orchestra BioMed has exceeded its full enrollment goal for the BACKBEAT Global Pivotal Trial testing AVIM Therapy, an innovative treatment integrated with pacemakers for patients with uncontrolled hypertension. The trial involves 330 patients randomized globally, surpassing the target of 316. Results are expected in Q2 2027 and could support regula…
Taysha Gene Therapies announced multiple presentations at the 55th Child Neurology Society Annual Meeting highlighting new safety and efficacy data for its TSHA-102 gene therapy program targeting Rett syndrome. The company will present results from the REVEAL Part A Phase 1/2 clinical trial showing multi-domain functional gains, further supporting …
